APLM vs ARDX

Apollomics Inc. vs Ardelyx, Inc. — Valuation Comparison 2026

APLM

Biotechnology
Apollomics Inc.
Quality
1.8
out of 10
Value Trap
Price
$14.06
Last close
Models
8/13
Active
VS

ARDX

Biotechnology
Ardelyx, Inc.
Quality
6.1
out of 10
Value Trap
30
LOW
Price
$6.25
Last close
Models
11/13
Active

Model-by-Model Comparison

ModelType APLM Fair ValueAPLM Upside ARDX Fair ValueARDX Upside
Bayesian DCF Intrinsic $3.72 -73.5% $1.41 -77.4%
Earnings Power Value Intrinsic $1.72 -75.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $12.28 -11.9% $6.62 +5.9%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for APLM vs ARDX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APLM vs ARDX — Which Stock Is More Undervalued?

ARDX scores higher with a 6.1/10 quality rating vs APLM's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Apollomics Inc. (APLM) and Ardelyx, Inc. (ARDX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APLM currently trades at $14.06 with a QOC of 1.8/10, while ARDX trades at $6.25 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).